Zymeworks Appoints Dr. Kelvin Neu to the Board of Directors

Author's Avatar
Mar 16, 2020
Article's Main Image

Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced the appointment of Kelvin Neu, M.D., to its Board of Directors.